New York State Common Retirement Fund Nymox Pharmaceutical Corp Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.3 - $2.23 $410 - $704	-316 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$1.46 - $2.48 $52,098 - $88,496	-35,684 Reduced 99.12%	316 $0
Q2 2020 Aug 07, 2020	BUY	$2.1 - $4.6 $75,600 - $165,600	36,000 New	36,000 $128,000
Q2 2019 Aug 09, 2019	SELL	$1.33 - $2.12 $21,147 - $33,708	-15,900 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$3.12 - $4.33 $24,960 - $34,640	8,000 Added 101.27%	15,900 $53,000
Q4 2017 Feb 13, 2018	BUY	$3.29 - $4.06 $9,212 - $11,367	2,800 Added 54.9%	7,900 $26,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,100	5,100 $22,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.